CA2338122A1 - Macrophage scavenger receptor antagonists - Google Patents
Macrophage scavenger receptor antagonists Download PDFInfo
- Publication number
- CA2338122A1 CA2338122A1 CA002338122A CA2338122A CA2338122A1 CA 2338122 A1 CA2338122 A1 CA 2338122A1 CA 002338122 A CA002338122 A CA 002338122A CA 2338122 A CA2338122 A CA 2338122A CA 2338122 A1 CA2338122 A1 CA 2338122A1
- Authority
- CA
- Canada
- Prior art keywords
- phenyl
- bromo
- group
- phenylenediamine
- dichloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9336198P | 1998-07-20 | 1998-07-20 | |
US60/093,361 | 1998-07-20 | ||
PCT/US1999/016347 WO2000003704A1 (en) | 1998-07-20 | 1999-07-20 | Macrophage scavenger receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2338122A1 true CA2338122A1 (en) | 2000-01-27 |
Family
ID=22238497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002338122A Abandoned CA2338122A1 (en) | 1998-07-20 | 1999-07-20 | Macrophage scavenger receptor antagonists |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1100484A1 (de) |
JP (1) | JP2003521446A (de) |
CA (1) | CA2338122A1 (de) |
WO (1) | WO2000003704A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1297848A4 (de) * | 2000-06-16 | 2004-05-19 | Chugai Pharmaceutical Co Ltd | Prophylaktische / therapeutische mittel für granuloma |
CN1622832A (zh) * | 2001-02-23 | 2005-06-01 | 布里斯托尔-迈尔斯斯奎布药品公司 | 用于动脉粥样硬化和易病变性斑块成像的标记的巨噬细胞清除剂受体拮抗剂 |
AUPR738301A0 (en) * | 2001-08-30 | 2001-09-20 | Starpharma Limited | Chemotherapeutic agents |
EP1429765A2 (de) | 2001-09-14 | 2004-06-23 | Methylgene, Inc. | Histone deacetylase-hemmer |
US6897220B2 (en) | 2001-09-14 | 2005-05-24 | Methylgene, Inc. | Inhibitors of histone deacetylase |
AU2006252047B2 (en) * | 2001-09-14 | 2010-02-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
US7868204B2 (en) | 2001-09-14 | 2011-01-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
EP1663953A1 (de) | 2003-09-24 | 2006-06-07 | Methylgene, Inc. | Histondeacetylase-hemmer |
US7253204B2 (en) | 2004-03-26 | 2007-08-07 | Methylgene Inc. | Inhibitors of histone deacetylase |
JP5554988B2 (ja) | 2006-04-07 | 2014-07-23 | メチルジーン インコーポレイテッド | ヒストンデアセチラーゼの阻害剤 |
-
1999
- 1999-07-20 JP JP2000559839A patent/JP2003521446A/ja not_active Withdrawn
- 1999-07-20 EP EP99935715A patent/EP1100484A1/de not_active Withdrawn
- 1999-07-20 WO PCT/US1999/016347 patent/WO2000003704A1/en not_active Application Discontinuation
- 1999-07-20 CA CA002338122A patent/CA2338122A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2003521446A (ja) | 2003-07-15 |
WO2000003704A1 (en) | 2000-01-27 |
EP1100484A1 (de) | 2001-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU730261B2 (en) | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity | |
US6458845B1 (en) | Macrophage scavenger receptor antagonists | |
AU2012289961C1 (en) | Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same | |
WO1997046228A9 (en) | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity | |
CA2379657A1 (en) | Phosphate transport inhibitors | |
CA2338122A1 (en) | Macrophage scavenger receptor antagonists | |
US6255298B1 (en) | Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases | |
US9630915B2 (en) | Thromboxane receptor antagonists | |
WO2001087294A1 (en) | Phosphate transport inhibitors | |
CA2339094A1 (en) | Macrophage scavenger receptor antagonists | |
US20030216449A1 (en) | Phosphate transport inhibitors | |
WO2001098264A1 (en) | Macrophage scavenger receptor antagonists | |
CA2475454A1 (en) | Aryl-n-cyanoguanidines and methods related thereto | |
JPH06502632A (ja) | スルホンアミドを含む医薬組成物、新規なスルホンアミド類およびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |